National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Budapest, Hungary.
Front Immunol. 2021 Oct 11;12:705422. doi: 10.3389/fimmu.2021.705422. eCollection 2021.
Detecting the entire repertoire of tumor-specific reactive tumor-infiltrating lymphocytes (TILs) is essential for investigating their immunological functions in the tumor microenvironment. Current assays identifying tumor-specific functional activation measure the upregulation of surface molecules, production of antitumor cytokines, or mobilization of cytotoxic granules following recognition of tumor-antigens, yet there is no widely adopted standard method. Here we established an enhanced, yet simple, method for identifying simultaneously CD8 and CD4 tumor-specific reactive TILs , using a combination of widely known and available flow cytometry assays. By combining the detection of intracellular CD137 and production of TNF and IFNγ after recognition of naturally-presented tumor antigens, we demonstrate that a larger fraction of tumor-specific and reactive CD8 TILs can be detected compared to commonly used assays. This assay revealed multiple polyfunctionality-based clusters of both CD4 and CD8 tumor-specific reactive TILs. , the combined detection of , , and identified most of the tumor-specific reactive TIL repertoire. In conclusion, we describe a straightforward method for efficient identification of the tumor-specific reactive TIL repertoire , which can be rapidly adopted in most cancer immunology laboratories.
检测肿瘤特异性反应性肿瘤浸润淋巴细胞(TIL)的整个库对于研究其在肿瘤微环境中的免疫功能至关重要。目前鉴定肿瘤特异性功能激活的检测方法测量表面分子的上调、抗肿瘤细胞因子的产生或识别肿瘤抗原后细胞毒性颗粒的动员,但没有广泛采用的标准方法。在这里,我们建立了一种增强但简单的方法,用于同时识别 CD8 和 CD4 肿瘤特异性反应性 TIL,使用广泛已知和可用的流式细胞术检测的组合。通过结合检测自然存在的肿瘤抗原后细胞内 CD137 和 TNF 和 IFNγ 的产生,我们证明与常用的检测方法相比,可以检测到更大比例的肿瘤特异性和反应性 CD8 TIL。该检测方法揭示了基于多种多功能性的 CD4 和 CD8 肿瘤特异性反应性 TIL 群。总之,我们描述了一种用于有效鉴定肿瘤特异性反应性 TIL 库的简单方法,该方法可以在大多数癌症免疫学实验室中快速采用。